NewsBenzingaアニカ・セラピューティクス、第3四半期調整後EPSは0.29ドルで予想の0.06ドルを上回る、売上高は3,059.4万ドルで予想の2,943.6万ドルを上回る アニカ・セラピューティクス、第3四半期調整後EPSは0.29ドルで予想の0.06ドルを上回る、売上高は3,059.4万ドルで予想の2,943.6万ドルを上回る Benzinga 2026.11.06 12:06 (GMT+0) Open on Benzinga Other news Snowflake-Led AI Group Wins US Export Program Backing Solflare CEO: AI Security Reviews Being Built Into Development Pipeline, MoneyGram Integration Enables USDC-to-Cash Redemption Lighter Security Incident Update: About 5 Million USDC Returned to Affected Users, Withdrawals Resumed Supply Chain Attack on Optimizely Affects at Least 186 Websites, Aimed at Stealing Crypto Assets and Payment Info Cybersecurity AI startup Corma reaches $1B valuation in about 3 months Here’s How Much You Would Have Made Owning Advanced Micro Devices Stock In The Last 15 Years
Solflare CEO: AI Security Reviews Being Built Into Development Pipeline, MoneyGram Integration Enables USDC-to-Cash Redemption
Lighter Security Incident Update: About 5 Million USDC Returned to Affected Users, Withdrawals Resumed
Supply Chain Attack on Optimizely Affects at Least 186 Websites, Aimed at Stealing Crypto Assets and Payment Info